Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Catalyst Pharmaceuticals, Inc.”

2 pharma patents match "Catalyst Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 2 pharmaceutical patents matching "Catalyst Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2 results for “Catalyst Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9254274

    Method of treating Tourette'S disorder with GABA-aminotransferase inactivators

    Catalyst Pharmaceuticals, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  2. US 8969413

    Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid

    Catalyst Pharmaceuticals, Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.